IASR Vol.47 No.1 (No. 551) January 2026 Pertussis in Japan, as at November 2025
PDFdownload（PDF：539KB）
Pertussis in Japan, as at November 2025
- Pertussis vaccination in Japan
- Pertussis outbreak identified through multiplex PCR testing and other diagnostic methods, Shiga Prefecture, Japan
- Summary of the epidemiology of pertussis in Japan in 2025 based on the Pertussis Reporting Guidelines for Physicians based on the Infectious Diseases Control Law
- Global epidemiological situation of pertussis
- Fundamentals of Bordetella pertussis and recent trends in molecular epidemiology
- Updates in diagnostic methods for macrolide-resistant Bordetella pertussis (MRBP)
- Treatment approaches for macrolide-resistant pertussis based on pathogen testing
- Prevalence and genomic analysis of macrolide-resistant Bordetella pertussis (MRBP), Okinawa Prefecture, Japan
- Investigation of macrolide resistance status in Bordetella pertussis detected within the prefecture, Ehime Prefecture, Japan
- Epidemiological situation of macrolide-resistant Bordetella pertussis (MRBP), Toyama Prefecture, Japan
- Development of the Guidelines on Prevention of Specified Infectious Diseases for acute respiratory infections (ARI) in Japan
- Overview of key issues in the regulatory review for approval of Xofluza: risk of emergence of low-susceptibility viruses in younger age groups associated with the expansion of pediatric indications and corresponding countermeasures
- Detection of carbapenem-resistant Enterobacterales (CRE) harboring the IMP-4 carbapenemase gene (blaIMP-4) in a patient returning from overseas
- Comparison of genetic detection methods and culture methods for the detection of Bordetella pertussis
